Skip Navigation

Annals of Oncology 2009 20(Supplement 4):iv29-iv31; doi:10.1093/annonc/mdp120
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Baekelandt, M. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Baekelandt, M. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

ESMO clinical recommendations

Endometrial carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

M. M. Baekelandt1, M. Castiglione2 and On behalf of the ESMO Guidelines Working Group*

1 Department of Gynecological Oncology, The Norwegian Radium Hospital, Oslo, Norway
2 Institute of Social and Preventive Medicine (ISPM), University of Geneva, Geneva, Switzerland

* Correspondence to: ESMO Guidelines Working Group, ESMO Head Office, Via L. Taddei 4, CH-6962 Viganello-Lugano, Switzerland; E-mail: clinicalrecommendations@esmo.org

The first 10% of the full text of this article appears below.


   incidence
 
The crude incidence of endometrial carcinoma in the European Union is 16 cases/100 000 women/year (range 13–24). The mortality is 4–5 cases/100 000/year. The lifetime risk of developing endometrial carcinoma is ~1.7–2%, and age-standardized incidence rates continue to rise in most developed countries.


   diagnosis
 
The diagnosis of endometrial carcinoma requires histopathological confirmation. This diagnosis is made according to the WHO pathological classification. About 80% of endometrial carcinomas are of endometrioid type. Serous (5–10%), clear cell (1–5%), mucinous, mixed, squamous cell, transitional cell . . . [Full Text of this Article]


   staging and risk assessment
 
degree of differentiation:

   treatment plan
 
stage I
stage II
stages III and IV

   follow-up
 

   note
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?